10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001410578-22-002040`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	enzn-20220630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 60 Cash Flow Statement 16 Stockholders Equity 22

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.79M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$47.64M	USD	Point-in-time
Royalty and milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$28.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$85.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$430.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.75M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.22M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets (all current)	`Assets`	$47.22M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total assets (all current)	`Assets`	$47.75M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.96M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$331.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$46.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$72.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$403.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$377.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.21M	shares	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 2,960,000 shares; no shares issued and outstanding at June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2022 and December 31, 2021	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 74,214,603 shares at June 30, 2022 and December 31, 2021	`CommonStockValue`	$742.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.98M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$74.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.05M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.34M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.87M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.87M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.30M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.22M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$47.75M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	-	USD	1 Quarter
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$672.00K	USD	2 Qtrs
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$291.00K	USD	1 Quarter
Total revenues	`Revenues`	$291.00K	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$672.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$303.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$312.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$682.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$600.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$682.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$312.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$303.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$600.00K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-21.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.00K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-600.00K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-303.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$92.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$4.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$90.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$2.00K	USD	1 Quarter
Loss before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.00K	USD	1 Quarter
Loss before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-213.00K	USD	1 Quarter
Loss before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-508.00K	USD	2 Qtrs
Loss before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-4.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$2.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-291.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-213.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-504.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$11.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.00K	USD	2 Qtrs
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.01M	USD	2 Qtrs
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$531.00K	USD	1 Quarter
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$1.06M	USD	2 Qtrs
Dividends on Series C preferred stock	`PreferredStockDividendsIncomeStatementImpact`	$506.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-744.00K	USD	1 Quarter
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.02M	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.57M	USD	2 Qtrs
Net loss available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-525.00K	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	2 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74,215.00	shares	2 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	2 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74,215.00	shares	2 Qtrs

Cash Flow Statement 16 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-504.00K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-8.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$343.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-57.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-847.00K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$49.00K	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-847.00K	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$49.00K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.79M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.64M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.19M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.14M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.79M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.64M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.19M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.14M	USD	Point-in-time

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$4.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.30M	USD	Point-in-time
Net Income (Loss)	`NetIncomeLoss`	$-291.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-213.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-504.00K	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-19.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$11.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-8.00K	USD	2 Qtrs
Preferred stock dividend accumulation	`DividendsCommonStockStock`	$531.00K	USD	1 Quarter
Preferred stock dividend accumulation	`DividendsCommonStockStock`	$506.00K	USD	1 Quarter
Preferred stock dividend accumulation	`DividendsCommonStockStock`	$506.00K	USD	1 Quarter
Preferred stock dividend accumulation	`DividendsCommonStockStock`	$531.00K	USD	1 Quarter
Balance	`StockholdersEquity`	$4.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.87M	USD	Point-in-time
Balance	`StockholdersEquity`	$3.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.